Evidence map›Paper›PMID 38046475›Full record

ArticleBehavioural neurology2023

Acceptance Factors and Psychological Investigation of Clinical Trials in Cancer Patients.

Jiangjie Sun, Jingyi Fang, Chenchen Zhang, Nannan Jia, Weiming Zhao, Jinjian Gao, Yingying Huang, Jiqing Hao, Liping Zhang

Abstract read
In one paragraph

Article in Behavioural neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Culturally Adapted Shared Decision-Making Tool for Breast Cancer Clinical Trials in China: A Nurse-Led Approach.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jiangjie SunSchool of Management, Hefei University of Technology, 230039, China.ORCID https://orcid.org/0000-0002-8185-0802
Jingyi FangFirst Clinical Medical College, Anhui Medical University, Hefei, Anhui 230032, China.
Chenchen ZhangFirst Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230032, China.
Nannan JiaFirst Clinical Medical College, Anhui Medical University, Hefei, Anhui 230032, China.
Weiming ZhaoFirst Clinical Medical College, Anhui Medical University, Hefei, Anhui 230032, China.
Jinjian GaoFirst Clinical Medical College, Anhui Medical University, Hefei, Anhui 230032, China.
Yingying HuangFirst Clinical Medical College, Anhui Medical University, Hefei, Anhui 230032, China.
Jiqing HaoFirst Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230032, China.ORCID https://orcid.org/0000-0003-4533-4402
Liping ZhangSchool of Marxism, Anhui Medical University, Hefei, Anhui 230032, China.ORCID https://orcid.org/0000-0002-3242-0822

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: To understand the degree of oncology patients' awareness of drug clinical trials and oncology patients' willingness to participate in drug clinical trials and the factors influencing them. Methods: The differences in the relevant variables of patients' willingness to accept clinical trials were analyzed, and a descriptive analysis was done for the measurement data (mean and standard deviation). Pearson's correlation coefficient analysis was used to examine the correlation between willingness and the demographic variables. Stepwise regression analysis was used to explore the influencing factors of patients' willingness to accept clinical trials. Results: There were no statistical differences in age, gender, education level, marital status, place of residence, monthly income, medical payment method, and treatment time ( Conclusion: Age, treatment time, and whether they had been subjects were the direct influencing factors of patients' willingness. This study pointed out that hospitals should do a good job in the publicity of clinical trials of new drugs, expand publicity channels, increase publicity efforts, improve the awareness of clinical trials of the masses, and promote the enthusiasm of the masses to participate in clinical trials of drugs.

Indexed as

Clinical Trials as TopicNeoplasmsPatient ParticipationHumans

Identifiers

PMID38046475
PMCPMC10691887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.